|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
254,036,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$22.93 - $22.93 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fuhrmann Rochelle |
Senior V.P., Finance |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,076) |
0 |
|
- |
|
Fenton Andrew |
Senior V.P., CIO |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,840) |
0 |
|
- |
|
Ellman Herman |
Senior V.P., Clinical Devel. |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(165,753) |
0 |
|
- |
|
Gilligan Claire A |
Senior V.P., Quality |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(28,049) |
0 |
|
- |
|
Gilligan Claire A |
Senior V.P., Quality |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(62,162) |
0 |
|
- |
|
Cross Leland H |
Senior V.P. |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(189,356) |
0 |
|
- |
|
Halstead Michael |
Senior V.P., Corp. Development |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,370) |
0 |
|
- |
|
Boissonneault Roger M |
CEO & President |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(300,000) |
0 |
|
- |
|
Boissonneault Roger M |
CEO & President |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,195,498) |
0 |
|
- |
|
Bloem James H |
Director |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,176) |
0 |
|
- |
|
Howard Alvin D |
Sr. V.P., Regulatory Affairs |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(84,219) |
0 |
|
- |
|
Herendeen Paul |
Exec. V.P. and CFO |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(94,900) |
0 |
|
- |
|
King John A |
Director |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,354,046) |
0 |
|
- |
|
Rodriguez Rama Francisco |
Senior V.P., Tech. Operations |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,109) |
0 |
|
- |
|
Sullivan Ryan T |
VP, General Counsel & Secr. |
|
2013-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,040) |
0 |
|
- |
|
Howson Tamar D |
Director |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,170) |
0 |
|
- |
|
Fuhrmann Rochelle |
Senior V.P., Finance |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
41,076 |
|
- |
|
Fenton Andrew |
Senior V.P., CIO |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
92,840 |
|
- |
|
Ellman Herman |
Senior V.P., Clinical Devel. |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
165,753 |
|
- |
|
Gilligan Claire A |
Senior V.P., Quality |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
62,162 |
|
- |
|
Cross Leland H |
Senior V.P. |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
189,356 |
|
- |
|
Halstead Michael |
Senior V.P., Corp. Development |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
36,370 |
|
- |
|
Boissonneault Roger M |
CEO & President |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(117,120) |
2,195,498 |
|
- |
|
Bloem James H |
Director |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,170) |
24,176 |
|
- |
|
Howard Alvin D |
Sr. V.P., Regulatory Affairs |
|
2013-09-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,470) |
84,219 |
|
- |
|
380 Records found
|
|
Page 1 of 16 |
|
|